Co-crystallisation and humanisation of an anti-HER2 single-domain antibody as a theranostic tool.
Human epidermal growth factor receptor-2 (HER2) is a well-recognised biomarker associated with 25% of breast cancers. In most cases, early detection and/or treatment correlates with an increased chance of survival. This study, has identified and characterised a highly specific anti-HER2 single-domai...
שמור ב:
| Principais autores: | , , , , , , , , , , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Public Library of Science (PLoS)
2023-01-01
|
| סדרה: | PLoS ONE |
| גישה מקוונת: | https://doi.org/10.1371/journal.pone.0288259 |
| תגים: |
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|
